Samrat Pharmachem Limited (SAMRATPH.BO)
BSE · INR · Basic Materials · Chemicals
₹269.00 (-2.13%) as of
Key statistics
- Market cap
- 831.13M
- EPS (TTM)
- -7.14
- Dividend yield
- 0.00%
- 52-week range
- 190.00 – 309.85
- Beta
- -0.19
- Revenue (TTM)
- 2.94B
- Profit margin
- -0.75%
- Volume
- 1.51k
About Samrat Pharmachem Limited
Samrat Pharmachem Limited manufactures and sells pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodine, iodine monochloride, iodoquinol, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate and iodide, potassium metaper iodate, povidone iodine, sodium iodate and iodide, and sodium metaper iodate. The company serves the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, printing, and textile industries. It also exports its products to the United States, Europe, Africa, Asia, the Middle East, and internationally. Samrat Pharmachem Limited was incorporated in 1992 and is based in Mumbai, India.
- Sector
- Basic Materials
- Industry
- Chemicals
- Headquarters
- Mumbai, India
- Employees
- 30
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.